2004
DOI: 10.1016/j.pbb.2003.12.019
|View full text |Cite
|
Sign up to set email alerts
|

Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
43
1

Year Published

2006
2006
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 81 publications
(52 citation statements)
references
References 39 publications
8
43
1
Order By: Relevance
“…The observed anxiogenic effects of cannabinoids agree with previous results in the emergence and EPM tests (Rodriguez de Fonseca et al, 1996;Arevalo et al, 2001;Caberlotto et al, 2004;Marco et al, 2004) and the social interaction test (Genn et al, 2004). Adolescent behavior in rodents is characterized by greater social interaction and exploratory behavior relative to adults (Spear, 2000) and such effects were evident in control rats in the social interaction and EPM tasks in the present study.…”
Section: Acute Anxiogenic Effects Of Thcsupporting
confidence: 93%
“…The observed anxiogenic effects of cannabinoids agree with previous results in the emergence and EPM tests (Rodriguez de Fonseca et al, 1996;Arevalo et al, 2001;Caberlotto et al, 2004;Marco et al, 2004) and the social interaction test (Genn et al, 2004). Adolescent behavior in rodents is characterized by greater social interaction and exploratory behavior relative to adults (Spear, 2000) and such effects were evident in control rats in the social interaction and EPM tasks in the present study.…”
Section: Acute Anxiogenic Effects Of Thcsupporting
confidence: 93%
“…The observation that THC reduced reactivity to threat-related stimuli is consistent with other evidence that cannabinoids play a role in fear and anxiety. Although high doses of THC may appear to increase anxiety (D'Souza et al, 2004;Genn et al, 2004;Viveros et al, 2005), low doses of cannabinoid receptor (CB 1 ) agonists, including THC, attenuate anxiety responses in animal models of fear and anxiety, including the elevated plus-maze and social interaction tests (Onaivi et al, 1990;Navarro et al, 1993;Rodriguez de Fonseca et al, 1997;Berrendero and Maldonado, 2002). In contrast, genetic disruption of the CB 1 receptor and selective pharmacological CB 1 antagonism enhance anxiety responses (Rodriguez de Fonseca et al, 1997;Hajos and Freund, 2002;Haller et al, 2002;Martin et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…In the elevated plus maze, cannabinoid agonists generally produce anxiogenic effects at high doses and anxiolytic effects at low doses (Arevalo et al, 2001;Berrendero and Maldonado, 2002;Marin et al, 2003;Marco et al, 2004). In the social interaction test (File, 1992;File and Seth, 2003;Genn et al, 2004) and defensive withdrawal test (Rodriguez de Fonseca et al, 1996;Yang et al, 1992), cannabinoid agonists and psychomotor stimulants can both produce anxiogenic effects. Acute administration of cocaine has been found to be anxiogenic in the light/dark test (Costall et al, 1989b), elevated plus maze (DeVries and Pert, 1998;Paine et al, 2002;Rogerio and Takahashi, 1992;Yang et al, 1992), drinking conflict test (Fontana and Commissaris, 1989), pentylenetetrazol drug discrimination (Shearman and Lal, 1981), and runway self-administration procedures (Ettenberg, 2004).…”
Section: Discussionmentioning
confidence: 99%